Zentalis Pharmaceuticals Inc. (ZNTL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.61
-0.05 (-3.01%)
At close: Oct 03, 2025, 3:59 PM
1.61
0.00%
After-hours: Oct 03, 2025, 06:36 PM EDT

Zentalis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
33.9M 28.04M 43.07M 59.71M
Short-Term Investments
337.18M 454.88M 394.3M 280.17M
Long-Term Investments
n/a 2.68M 21.21M 37.49M
Other Long-Term Assets
7.04M 6.82M -1.8M 2.63M
Receivables
5M n/a 7.04M 2.63M
Inventory
n/a n/a -7.04M -4.44M
Other Current Assets
n/a n/a n/a 2.05M
Total Current Assets
386.07M 496.72M 451.93M 350.77M
Property-Plant & Equipment
37.23M 41.73M 50.08M 52.84M
Goodwill & Intangibles
n/a 3.74M 3.74M 3.74M
Total Long-Term Assets
44.27M 54.97M 87.38M 103.74M
Total Assets
430.34M 551.69M 539.31M 454.51M
Account Payables
7.44M 14.93M 11.25M 11.59M
Deferred Revenue
n/a n/a -2.16M n/a
Short-Term Debt
3.07M 2.62M 2.16M 1.45M
Other Current Liabilities
n/a -2.62M 384K 20.2M
Total Current Liabilities
52.73M 69.37M 56.65M 43.94M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
849K 1.78M 2.62M n/a
Total Long-Term Liabilities
40.43M 44.93M 48.64M 46.08M
Total Liabilities
93.15M 114.3M 105.29M 90.03M
Total Debt
39.58M 43.15M 47.33M 45.91M
Book Value
337.19M 437.39M 434.02M 364.48M
Book Value Per Share
4.74 6.69 8.21 8.54
Common Stock
71K 70K 59K 45K
Retained Earnings
-1.05B -888.56M -596.37M -359.56M
Comprehensive Income
558K 2.19M -1.35M -125K
Shareholders Equity
337.19M 437.28M 434.02M 364.48M
Total Investments
337.18M 454.88M 415.51M 317.67M